Lawsuit Alleges Crestor Hid Diabetes Risks
Crestor Increased Risk Of Diabetes. A new lawsuit accuses AstraZeneca LP, and its distributor, McKesson Corp., of hiding ties between its cholesterol-lowering drug, Crestor (rosuvastatin), and increased risks for developing diabetes. The lawsuit was brought by a group of consumers over allegations that AstraZeneca and McKesson … [Read more...]
Crestor Side Effects May Be Linked To Kidney Damage Lawsuits
Crestor Side Effects Linked To Kidney Failure. Crestor has been linked to kidney damage and kidney failure. On October 22, 2004, the consumer group Public Citizen said twenty-nine patients who took AstraZeneca's cholesterol drug Crestor developed kidney damage. Crestor has also been linked to the potentially fatal disease … [Read more...]
Crestor Debate Intensifies
Crestor, The Newest In A Class Of Drugs Known As Statins. The Food and Drug Administration is raising questions about the cholesterol-lowering drug Crestor, the newest in a class of drugs known as statins. The consumer group Public Citizen has long been calling for Crestor's recall, citing a higher risk for a serious muscle … [Read more...]
Risks Posed By Crestor May Be Worse
Crestor Greater Risks Than Other Statins. The cholesterol-lowering "statin" drug Crestor (manufactured by AstraZeneca) has been the subject of controversy since it was first approved for sale in the United States in August 2003. While consumer groups like Public Citizen and medical experts (including FDA official and whistleblower, … [Read more...]
Safety Information Regarding Crestor
Crestor Updated Safety Information. Health Canada wishes to advise Canadians of safety concerns about Crestor, a cholesterol lowering drug, when used at the highest recommended dosage of 40 mg daily. The risk of rhabdomyolysis (muscle breakdown) may be increased at higher doses. Health Canada recommends that all patients taking … [Read more...]
Call for Withdrawal of Cholesterol Drug
Cholesterol Drug Crestor Can Cause Kidney Damage. A leading consumer watchdog group issued a new warning Friday about the cholesterol-lowering drug Crestor, alleging that patients who use it are 75 times likelier to suffer kidney damage than are patients using any other statin. Public Citizen has been urging the U.S. Food and Drug … [Read more...]
Advocate Suggests Crestor May Harm Kidneys
Advocates Renewed Effort To Get The Crestor Removed From Sale. Consumer advocate Dr. Sidney Wolfe renewed his effort Friday to get the anti-cholesterol drug Crestor removed from sale. Wolfe sent a letter to the Food and Drug Administration citing 29 cases of kidney problems 18 of kidney failure and 11 of kidney insufficiency out … [Read more...]
Advocacy Group Attacks AstraZeneca
A Group Attacks AstraZeneca. Public Citizen, which lobbied against the approval of Crestor, claims it has new evidence about the risks of taking the drug. The claims, to be published in a letter in Friday's edition of The Lancet, the medical journal, come two weeks after European regulators tightened the rules on prescribing … [Read more...]
More Illnesses to Cholesterol Drug
Illnesses Tied To Cholesterol Drug Crestor. A consumer health group, citing mounting cases of severe illness tied to the cholesterol-lowering drug Crestor, has taken its call for a ban on the pill to the pages of a leading medical journal. "To allow AstraZeneca to continue desperately seeking a piece of the estimated $20 … [Read more...]
AstraZeneca Drug Should Be Taken Off Market
AstraZeneca Should Be Removed From The Market. AstraZeneca Plc's Crestor cholesterol treatment is dangerous and should be removed from the market, a letter written by U.S. consumer watchdog Public Citizen and published in the British medical journal Lancet said. Sidney Wolfe, the head of Public Citizen's Health Research group, … [Read more...]
Association Between Crestor And Rhabdomyolysis
Crestor Associated By Rhabdomyolysis. Health Canada is advising Canadians about a possible association between the cholesterol lowering drug Crestor, and a serious condition called rhabdomyolysis. Rhabdomyolysis is a condition that results in muscle breakdown and the release of muscle cell contents into the bloodstream. Symptoms … [Read more...]
European Regulators Toughen Crestor Rules
Crestor Side Effects Injury Lawsuits. European drug regulators have tightened up the prescribing rules for Crestor, AstraZeneca's cholesterol lowering treatment, following problems with side effects. Doctors have been told they should start with low doses of the drug and must seek specialist advice before prescribing the highest, … [Read more...]
Caution When Prescribing Crestor
Crestor Can Cause Serious Toxicity. The FDA today advised doctors to be careful about how they prescribe Crestor, a potent cholesterol-fighting drug. The FDA advisory follows a new warning label released in Europe by Crestor maker Astra-Zeneca Pharmaceuticals. The changes are a response to recent reports of serious toxicity in … [Read more...]
Off-Label Crestor Use Warning Letter
Astrazeneca Warning Letter To Physicians. AstraZeneca Plc issued a warning letter to British physicians regarding off-label prescribing of its statin Crestor (rosuvastatin), Reuters reported. After discovering four cases of rhabdomyolysis a muscle toxicity condition that can lead to kidney damage among high-dose Crestor users, the … [Read more...]
Crestor Left Off Insurer Listing
Crestor Not On The List. A consultant to the nation's largest private health insurer and more than one-third of Fortune 500 companies did not include Crestor on a list of drugs it recommends for reimbursement by insurers and corporations. The decision by Medco Health Solutions Inc. is a blow to the new cholesterol drug AstraZeneca … [Read more...]
